Former FDA Commissioner Dr. Scott Gottlieb joins "Squawk Box" to discuss the charges that have been filed against one of the largest pharmaceutical companies in the country, Rochester Drug Cooperative, regarding the ongoing opioid crisis.
Rite Aid will raise the minimum age to buy tobacco products to 21 within the next 90 days, the company announced Tuesday.
The FDA put Walgreens "on notice" in February, accusing the pharmacy chain of violating rules that prohibit selling cigarettes and other tobacco products to underage buyers.
April 22- U.S. Food and Drug Administration:. *FDA STATEMENT ON "CONTINUED CONFIDENCE" IN SAFETY AND EFFECTIVENESS OF MEASLES, MUMPS, AND RUBELLA VACCINE. *FDA SAYS HAS DETERMINED THAT MEASLES, MUMPS AND RUBELLA VACCINE IS BOTH SAFE AND EFFECTIVE IN PREVENTING THESE DISEASES Source text for Eikon:.
The CDC confirmed 71 new cases of measles last week, bringing the total for the year to 626 cases. In 2010, the worst year on record since measles was said to be eradicated in the U.S., the CDC confirmed 667 cases.
April 19- Generic drugmaker Teva Pharmaceutical Industries Ltd on Friday received approval from the U.S. Food and Drug Administration to market its generic nasal spray for opioid overdose, the health regulator said. This is the first approval of a generic naloxone nasal spray for use in a community setting by individuals without medical training, the FDA said...
Senate Majority Leader Mitch McConnell will introduce legislation to raise the federal minimum age to buy tobacco to 21 from 18.
Carl's Jr. is the first fast food chain to announce plans to sell a CBD-infused burger.
It's one of the first major national retailers to sell CBD supplements since Congress legalized the cannabis derivative in December.
April 16- The U.S. Food and Drug Administration on Tuesday ordered makers of transvaginal surgical mesh implants to immediately stop sale and distribution of the products in the United States. In 2016, the agency had reclassified the mesh as class III or high risk, requiring its makers to submit and obtain approval from the FDA's most stringent device review...
Johnson & Johnson reported quarterly earnings and revenue that beat analysts' expectations even as it faces litigation over its talc baby powder and new competition against its prostate cancer drug Zytiga.
April 15- Amgen Inc on Monday set the U.S. list price for its new Evenity osteoporosis drug at $1,825 a month, or $21,900 for a full 12- month course of injections. The U.S. Food and Drug Administration last week approved bone-building Evenity for postmenopausal women who are at high risk of fracture, but required the label to have a boxed warning, the FDAs strictest,...
The pre-cut melon products have been recalled from Whole Foods, Kroger and other retailers across nine states reporting infections.
In the letters, dated April 5, the FDA asked the companies to submit a plan of action within 30 days, describing how they will address and mitigate illegal sales to minors. Retailers in particular are on the frontlines of these efforts to reduce the health consequences of tobacco use and nicotine dependence, "the FDA said in the letter. "The new retailer letters are...
Celgene brings to Bristol-Myers five late-stage products that could be approved in the near term, Caforio said.
Former FDA Commissioner Scott Gottlieb sits down with 'Power Lunch' to discuss the concern of marijuana entering the general society, e-cigarette sales and the measles outbreak in America.
Former FDA Commissioner Scott Gottlieb sits down with 'Power Lunch' to discuss the concern about marijuana entering general society, e-cigarette sales and the measles outbreak in America.
April 9- The U.S. Food and Drug Administration said on Tuesday it had approved Amgen Inc's osteoporosis treatment for postmenopausal women who are at high risk of fracture. Evenity comes with a boxed warning, the FDA's strictest warning, flagging increased risk of heart attack, stroke and cardiovascular-related death. "It's important to carefully select...
April 9- The U.S. Food and Drug Administration said on Tuesday it had approved Amgen Inc's osteoporosis treatment for postmenopausal women at high risk of fracture. Evenity comes with a boxed warning, the FDA's harshest, flagging increased risk of heart attack, stroke and cardiovascular-related death. "It's important to carefully select patients for this...
April 9- The U.S. Food and Drug Administration on Tuesday approved Amgen Inc's osteoporosis treatment for postmenopausal women at high risk for fracture, according to the regulator's website. The monthly injection, Evenity, developed jointly with Belgium- based UCB SA, helps reduce the risk of fracture by mildly inhibiting the break down of bone minerals.